Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

MYOKMYOK
8 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in MYOKARDIA INC

As of its Q3 2020 13F, Baker Bros. Advisors held 3,009,344 shares of MYOK (Myokardia), worth $410.3M. Baker Bros. Advisors' 13F filings listed MYOK from Q1 2019 to Q3 2020, 7 quarterly filings. MYOK was 1.6% of Baker Bros. Advisors' reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$52.8M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q3
Decreased
3M
-4.9%
$410.3M1.6%—
0
2020-Q2
Increased
3.2M
+78.3%
$305.7M1.3%—
74
2020-Q1
Unchanged
1.8M
0.0%
$83.2M0.5%—
0
2019-Q4
Increased
1.8M
+16.9%
$129.3M0.7%—
49
2019-Q3
Increased
1.5M
+49.3%
$79.1M0.5%—
58
2019-Q2
Unchanged
1M
0.0%
$51M0.3%—
0
2019-Q1
First report
1M
-
$52.8M0.3%—
0

Other major holders of MYOK: FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used